(Press-News.org) BETHESDA, MD – July 3, 2012 – As the Genetics Society of America's Model Organism to Human Biology (MOHB): Cancer Genetics Meeting in Washington, D.C. drew to a close, it was clear that the mantra for drug discovery to treat cancers in the post-genomic era is pathways.
Pathways are ordered series of actions that occur as cells move from one state, through a series of intermediate states, to a final action. Because model organisms – fruit flies, roundworms, yeast, zebrafish and others – are related to humans, they share many of the same pathways, but in systems that are much easier to study. Focusing on pathways in model organisms can therefore reveal new drug targets that may be useful in treating human disease.
"By reading evolution's notes, we can discover what really matters in the genome," keynote speaker Eric Lander, Ph.D., founding director of the Broad Institute of Harvard and MIT and professor of biology at MIT, told a packed crowd at the MOHB: Cancer Genetics Meeting on June 19.
What matters the most in the genome of a cancer cell may be the seeds of drug resistance, the genetic changes that enable cells to evade our best drugs. Bert Vogelstein, M.D., director of the Ludwig Center at Johns Hopkins University and an investigator with the Howard Hughes Medical Institute and a keynote speaker on June 17, told participants. He called drug resistance to single agents a "fait accompli," or a done deal as a side effect of the evolution of cancer.
"About 3,000 resistant cells are present in every visible metastasis," said Dr. Vogelstein. "That's why we see resistance with all therapeutics, even when they work. And we can't get around it with single agents. Cancer treatment requires combinations of agents."
Presentations throughout the meeting offered specific examples of events in pathways involved in the progression of cancer in model organisms that shed light on how human cancer may metastasize.
To identify the genes behind a breast cancer's spread to the lungs, Joan Massagué, Ph.D., chair of the Cancer Biology & Genetics Program at Memorial Sloan-Kettering Cancer Center and colleagues, placed cells from the lung fluid of patients into mice, deducing a "breast cancer lung metastasis signature" and identifying several mediators of metastasis that are clinically relevant and potential drug targets.
Denise Montell, Ph.D., from Johns Hopkins University School of Medicine, traced the signaling pathways that developing egg cells in the Drosophila (fruit fly) ovary use to migrate as using some of the same genes that are expressed as ovarian cancer spreads.
David Botstein, Ph.D., and his group at Princeton University use yeast to model the evolution of cancer through serial mutations, revealing that only a few destinations for a particular type of cancer are possible. "Breast cancers can't turn into leukemias, There are limited subtypes, not just anything can happen," he explained.
David Q. Matus, Ph.D., a postdoctoral researcher at Duke University, discussed an in vivo model of cell invasion, a key component of cancer metastasis that occurs during the larval development of the roundworm, Caenorhabditis elegans. He showed that the invasive gonadal anchor cell needs to exit the cell cycle, (be non-dividing), in order to invade. Proliferative anchor cells fail to form "invadopodia" -- invasive feet or protrusions in the basement membrane -- suggesting that cell division and cell invasion are disparate states.
The tumor suppressor "drivers" – those genes that reduce the probability of a cell turning into a cancer cell -- are often deletions -- part of a chromosome or a sequence of DNA that is missing. But, a drug can't target proteins encoded by such sequences. The solution? Understand and interrogate pathways. "For every mutated tumor suppressor gene that inactivates a component of a pathway, another gene is indirectly activated," Dr. Vogelstein explained. We need model organisms to dissect the pathways that will underlie future combination therapies, he concluded.
###
ABOUT THE MODEL ORGANISM TO HUMAN BIOLOGY MEETING: The GSA MOHB Meeting has been held every other year since 2006. The GSA Board of Directors developed this meeting to enable basic research scientists studying genetic diseases in model organisms and scientists studying these diseases in humans to have a forum for discussion of their findings and to forge collaborative investigations.
ABOUT GSA: Founded in 1931, the Genetics Society of America (GSA) is the professional membership organization for scientific researchers, educators, bioengineers, bioinformaticians and others interested in the field of genetics. Its nearly 5,000 members work to advance knowledge in the basic mechanisms of inheritance, from the molecular to the population level. GSA is dedicated to promoting research in genetics and to facilitating communication among geneticists worldwide through its conferences, including the biennial conference on Model Organisms to Human Biology, an interdisciplinary meeting on current and cutting edge topics in genetics research, as well as annual and biennial meetings that focus on the genetics of particular organisms, including C. elegans, Drosophila, fungi, mice, yeast, and zebrafish. GSA publishes GENETICS, a leading journal in the field and an online, open-access journal, G3: Genes|Genomes|Genetics. For more information about GSA, please visit www.genetics-gsa.org. Also follow GSA on Facebook at facebook.com/GeneticsGSA and on Twitter @GeneticsGSA.
Following the genomic pathways to stop the spread of cancer
2012-07-04
ELSE PRESS RELEASES FROM THIS DATE:
New animal model may lead to treatments for common liver disease
2012-07-04
Scientists at Texas Biomed have developed the laboratory opossum as a new animal model to study the most common liver disease in the nation – afflicting up to 15 million Americans – and for which there is no cure.
The condition, nonalcoholic steatohepatitis (NASH), resembles alcoholic liver disease, but occurs in people who drink little or no alcohol. The major feature of NASH is accumulation of fat in the liver, along with inflammation and functional damage. Most people with NASH feel well and are not aware that they have a liver problem. Nevertheless, NASH can progress ...
Diving shrews -- heat before you leap
2012-07-04
How does the world's smallest mammalian diver survive icy waters to catch its prey? A recent study of American water shrews to be presented at the Society for Experimental Biology meeting in Salzburg on 1st July has surprised researchers by showing that the animals rapidly elevate body temperature immediately before diving into cold water.
This behaviour is unexpected because lower body temperatures enable diving mammals to stay underwater for longer, so heating up doesn't make sense. This is because animals use up oxygen more quickly when they are warmer.
According ...
In McNeil's Nebula, a young star flaunts its X-ray spots
2012-07-04
Using combined data from a trio of orbiting X-ray telescopes, including NASA's Chandra X-ray Observatory and the Japan-led Suzaku satellite, astronomers have obtained a rare glimpse of the powerful phenomena that accompany a still-forming star. A new study based on these observations indicates that intense magnetic fields drive torrents of gas into the stellar surface, where they heat large areas to millions of degrees. X-rays emitted by these hot spots betray the newborn star's rapid rotation.
Astronomers first took notice of the young star, known as V1647 Orionis, in ...
Penn engineers convert a natural plant protein into drug-delivery vehicles
2012-07-04
PHILADELPHIA — Finding biocompatible carriers that can get drugs to their targets in the body involves significant challenges. Beyond practical concerns of manufacturing and loading these vehicles, the carriers must work effectively with the drug and be safe to consume. Vesicles, hollow capsules shaped like double-walled bubbles, are ideal candidates, as the body naturally produces similar structures to move chemicals from one place to another. Finding the right molecules to assemble into capsules, however, remains difficult.
Researchers from the University of Pennsylvania ...
The EU underpays Madagascar for access to fish: UBC research
2012-07-04
Unfair and exploitative political agreements allow Europeans to eat fish from the plates of developing countries, according to a study led by University of British Columbia researchers.
In the case of Madagascar, the European Union pays less than it did two decades ago while catching more fish. Since 1986, the EU's quotas for catching fish in Madagascar's waters have increased by 30 per cent while its access fees have decreased by 20 per cent. As a result, the total annual income for Madagascar decreased by almost 90 per cent between 1986 and 2010.
An international ...
Study sheds light on pregnancy complications and overturns common belief
2012-07-04
A study led by Hospital for Special Surgery researchers has demonstrated that women who have a specific type of antibody that interferes with blood vessel function are at risk for adverse pregnancy outcomes and that other antibodies in the same family thought to cause pregnancy complications do not put women at risk.
The researchers say that many doctors may be unnecessarily treating some pregnant women who have antiphospholipid antibodies (aPLs) with anticoagulants, such as expensive heparin injections, which can cause bleeding and bone loss. The multicenter study appears ...
Researchers from Penn, Michigan and Duke study how cooperation can trump competition in monkeys
2012-07-04
PHILADELPHIA— Being the top dog — or, in this case, the top gelada monkey — is even better if the alpha male is willing to concede at times to subordinates, according to a study by researchers from the University of Pennsylvania, the University of Michigan and Duke University.
Alpha male geladas who allowed subordinate competitors into their group had a longer tenure as leader, resulting in an average of three more offspring each during their lifetimes.
The findings, collected from data during a five-year period ending in January 2011 through the University of Michigan ...
New method knocks out stubborn electron problem
2012-07-04
A newly published article in Physical Review Letters eliminates one of the top unsolved theoretical problems in chemical physics as ranked by the National Research Council in 1995. Scientists now can more accurately predict the dynamic behavior of electrons in atoms and molecules in chemical reactions that govern a wide range of phenomena, including the fuel efficiency of combustion engines and the depletion of the atmospheric ozone.
The paper by David Mazziotti, professor in chemistry at the University of Chicago, solves what specialists call the "N-representability ...
Single embryo transfer reduces the risk of perinatal mortality in IVF
2012-07-04
Istanbul, 4 July 2012: A policy of single embryo transfer (SET) reduces the risk of perinatal mortality in infants born as a result of IVF and ICSI. The conclusion emerged from an analysis of more than 50,000 births recorded in the Australian and New Zealand Assisted Reproduction Technology Database between 2004 and 2008, where the introduction of an SET policy has been associated with a reduction in overall perinatal mortality for IVF and ICSI babies.
Results of the analysis were presented here today at the annual meeting of ESHRE (European Society of Human Reproduction ...
Freezing all embryos in IVF with transfer in a later non-stimulated cycle may improve outcome
2012-07-04
Istanbul, 4 July 2012: There is growing interest in a "freeze-all" embryo policy in IVF. Such an approach, which cryopreserves all embryos generated in a stimulated IVF cycle for later transfer in a non-stimulated natural cycle, would avoid any of the adverse effects which ovarian stimulation might have on endometrial receptivity during the treatment cycle. Ovarian stimulation has been shown to have adverse effects on endometrial receptivity and the risk of ovarian hyperstimulation syndrome (OHSS) is also increased when embryo transfer is performed in the stimulated cycle.
Freezing ...